Therapeuticsmd Inc Revenue per Employee (TXMD), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Therapeuticsmd Inc   (NASDAQ: TXMD)
 

Therapeuticsmd Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Therapeuticsmd Inc 's Revenue per employee fell on a trailing twelve month basis to $ 3,270,000, but the productivity of Therapeuticsmd Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 17 other companies have achieved higher revenue per employee. While Therapeuticsmd Inc 's total ranking has deteriorated compared to the previous quarter from 245 to 271. Therapeuticsmd Inc has 1 employees.


What is Sales per Employee Ratio?







TXMD Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -8.72 % 84.22 % 33.88 % 43.33 % 306.84 %
Sales per Employee (TTM) $ 3,270,000 3,353,000 3,022,000 2,796,000 2,559,000
TXMD's Total Ranking # 271 # 245 # 3025 # 2266 # 2883
Seq. Revenue Change 20.03 % -18.92 % 13.9 % -17.65 % 142.24 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 18
Overall Market # 271

Revenue per Employee Statistics
High Average Low
$ 91,978,000 $ 26,427,820 $ 917,000
(Jun 30 2022)   (Jun 30 2024)



Financial Statements
Therapeuticsmd Inc 's Revenue MRQ $ 1 Millions Visit TXMD's Income Statement
Therapeuticsmd Inc 's Revenues TTM $ 3 Millions Visit TXMD's aggregate revenue growth
What are TXMD's Sales? Visit TXMD's Sales by Segment




Other Ratios
Therapeuticsmd Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TXMD's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TXMD's Competitors
Revenue per Employee for TXMD's Suppliers
Revenue per Employee for TXMD's Customers

You may also want to know
TXMD's Sales Growth Rates TXMD's Pe Price to earnings ratio TXMD's Receivables Turnover Ratio TXMD's Stock Quote
TXMD's Net Income Growth Rates TXMD's Ps Price to Sales ratio TXMD's Sales per Employee TXMD's Asset Turnover Ratio
TXMD's Net Margin TXMD's Pb Price to Book ratio TXMD's Financial Strength Ratios TXMD's Dividend Payout Ratio
Date modified: 2026-09-05T00:18:07+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.